LG 101506: High-Purity RXR Modulator for Nuclear Receptor Signaling Research

Executive Summary: LG 101506 (B7414) is a small molecule modulator of the Retinoid X Receptor (RXR) with a defined molecular weight of 420.53 and 98% purity, optimized for research use only (APExBIO). It supports high solubility in DMSO (42.05 mg/ml) and ethanol (21.03 mg/ml) under standard laboratory conditions. RXR signaling, modulated by LG 101506, is central to nuclear receptor biology and metabolism regulation (Zhang et al., 2022). The compound is shipped under temperature-controlled conditions and requires storage at -20°C for stability. LG 101506 facilitates studies in immune checkpoint regulation and cancer, especially in immune-cold models like triple-negative breast cancer (TNBC).

Biological Rationale

The Retinoid X Receptor (RXR) is a nuclear receptor that regulates transcription in response to ligand binding. RXR partners with other nuclear receptors to control gene expression impacting cell differentiation, metabolism, and immune function (Zhang et al., 2022). Aberrant RXR signaling is implicated in metabolic disorders and cancer biology. In immune-cold tumors, such as most TNBCs, immune evasion is partly driven by suppressed effector T cell infiltration and aberrant checkpoint protein expression. Modulating RXR pathways can influence these immune landscapes by altering transcriptional programs in both cancer and immune cells. LG 101506, with its high-purity and defined solubility, offers precise control for researchers studying these complex signaling networks.

Mechanism of Action of LG 101506

LG 101506 is a synthetic RXR modulator with the chemical name (2E,4E,6Z)-7-(3,5-di-tert-butyl-2-(2,2-difluoroethoxy)phenyl)-3-methylocta-2,4,6-trienoic acid. It binds to the ligand-binding domain of RXR, influencing its conformation and co-regulator recruitment. This modulation adjusts RXR’s ability to heterodimerize with partners such as PPAR, LXR, and RAR, resulting in altered gene transcription (see also: LG 101506: Transforming RXR Signaling Pathway Research). LG 101506 acts as a research tool to dissect RXR’s role in cellular signaling, enabling mechanistic studies in metabolism regulation, immune checkpoint expression, and nuclear receptor-driven disease models. Unlike generic retinoids, LG 101506 offers greater specificity and reproducibility due to its defined purity and solubility profile.

Evidence & Benchmarks

• LG 101506 demonstrates solubility of 42.05 mg/ml in DMSO and 21.03 mg/ml in ethanol at room temperature, facilitating high-concentration stock preparations (APExBIO).
• RXR modulation influences gene networks regulating metabolism, immune response, and cancer cell differentiation (Zhang et al., 2022).
• In TNBC, RXR pathway activity intersects with immune checkpoint regulation, including PD-L1 expression, impacting therapeutic response (Zhang et al., 2022).
• APExBIO provides validated quality controls (98% purity by HPLC) and stability data for LG 101506 (B7414), supporting reproducible research (product page).
• Recent studies show small molecule RXR ligands can modulate post-transcriptional and post-translational checkpoints in cancer models (see also: Rewiring the RXR Signaling Axis).

Applications, Limits & Misconceptions

LG 101506 is used in RXR signaling pathway research, nuclear receptor-related disease models, and mechanistic studies of tumor immunity. Its utility includes:

• Metabolism regulation studies—probing RXR’s role in lipid and glucose homeostasis.
• Cancer biology—dissecting transcriptional control of immune checkpoints in models such as TNBC (Zhang et al., 2022).
• Cellular signaling—mapping RXR-dependent gene networks and their crosstalk with other nuclear receptors.

LG 101506 is not intended for diagnostic or therapeutic use in humans. It should not be assumed to have efficacy in all RXR-expressing cell types or disease contexts. Dosage and exposure must be optimized for each experimental system. For a detailed workflow integration and troubleshooting guide, see LG 101506: RXR Modulator Workflows for Nuclear Receptor Research, which this article extends by providing updated evidence on immune checkpoint regulation.

Common Pitfalls or Misconceptions

• LG 101506 is not suitable for clinical therapy or diagnostic procedures—research use only (APExBIO).
• Long-term storage of LG 101506 solutions (>1 week) at ambient temperature may reduce activity; use freshly prepared solutions and store at -20°C.
• The compound’s effects are context-dependent; observed results in one cell line or model may not generalize to others.
• RXR modulation by LG 101506 does not directly target PD-L1 or other immune checkpoints, but can influence their expression via gene regulatory networks (Zhang et al., 2022).
• Solubility data applies to DMSO and ethanol; aqueous solubility is limited and may require co-solvents.

Workflow Integration & Parameters

LG 101506 is supplied as an off-white solid with 98% purity (HPLC) by APExBIO. It is stable when shipped on blue ice (small molecule) or dry ice (modified nucleotide formulations). For maximum stability, store at -20°C and avoid repeated freeze-thaw cycles. Prepare stock solutions in DMSO (up to 42.05 mg/ml) or ethanol (up to 21.03 mg/ml). Use freshly prepared working solutions for cell-based or biochemical assays. For optimal results, titrate compound concentrations in pilot studies to identify effective ranges for specific cell systems. LG 101506 can be integrated into workflows for gene expression profiling, chromatin immunoprecipitation, or metabolic flux analysis. For strategic guidance on RXR modulation in precision medicine, see Precision RXR Modulation—this article clarifies the compound’s properties and standardized usage protocols.

Conclusion & Outlook

LG 101506 is a high-purity RXR modulator that empowers researchers to dissect nuclear receptor signaling with precision. Its robust solubility, defined chemical identity, and validated stability support reproducible experimental outcomes. By facilitating studies in metabolism, immune checkpoint biology, and cancer, LG 101506 accelerates advances in nuclear receptor research. Future directions include expanding its use in combinatorial pathway analysis and translational models of disease. For full specifications and ordering information, see the LG 101506 product page.